Literature DB >> 12854143

Mast cells and human hepatocellular carcinoma.

Fabio Grizzi1, Barbara Franceschini, Maurizio Chiriva-Internati, Young Liu, Paul L Hermonat, Nicola Dioguardi.   

Abstract

AIM: To investigate the density of mast cells (MCs) in human hepatocellular carcinoma (HCC), and to determine whether the MCs density has any correlations with histopathological grading, staging or some baseline patient characteristics.
METHODS: Tissue sections of 22 primary HCCs were histochemically stained with toluidine blue, in order to be able to quantify the MCs in and around the neoplasm using a computer-assisted image analysis system. HCC was staged and graded by two independent pathologists. To identify the sinusoidal capillarisation of each specimen 3 ?m thick sections were histochemically stained with sirius red, and semi-quantitatively evaluated by two independent observers. The data were statistically analysed using Spearman's correlation and Student's t-test when appropriate.
RESULTS: MCs density did not correlate with the age or sex of the patients, the serum alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels, or the stage or grade of the HCC. No significant differences were found between the MCs density of the patients with and without hepatitis C virus infection, but they were significantly higher in the specimens showing marked sinusoidal capillarisation.
CONCLUSION: The lack of any significant correlation between MCs density and the stage or grade of the neoplastic lesions suggests that there is no causal relationship between MCs recruitment and HCC. However, as capillarisation proceeds concurrently with arterial blood supply during hepatocarcinogenesis, MCs may be considered of primary importance in the transition from sinusoidal to capillary-type endothelial cells and the HCC growth.

Entities:  

Mesh:

Year:  2003        PMID: 12854143      PMCID: PMC4615484          DOI: 10.3748/wjg.v9.i7.1469

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  44 in total

1.  Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue.

Authors:  H J Nielsen; U Hansen; I J Christensen; C M Reimert; N Brünner; F Moesgaard
Journal:  J Pathol       Date:  1999-12       Impact factor: 7.996

2.  Myofibroblasts in the cirrhotic rat liver reflect hepatic remodeling and correlate with fibrosis and sinusoidal capillarization.

Authors:  A Zimmermann; D Zhao; J Reichen
Journal:  J Hepatol       Date:  1999-04       Impact factor: 25.083

3.  The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus.

Authors:  G O Elpek; T Gelen; N H Aksoy; A Erdoğan; L Dertsiz; A Demircan; N Keleş
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

4.  Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.

Authors:  T Terada; Y Matsunaga
Journal:  J Hepatol       Date:  2000-12       Impact factor: 25.083

5.  Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor.

Authors:  R Tóth-Jakatics; S Jimi; S Takebayashi; N Kawamoto
Journal:  Hum Pathol       Date:  2000-08       Impact factor: 3.466

6.  Effect of mast cells on tumor angiogenesis in lung cancer.

Authors:  M Tomita; Y Matsuzaki; T Onitsuka
Journal:  Ann Thorac Surg       Date:  2000-06       Impact factor: 4.330

7.  Metallothionein expression in hepatocellular carcinoma.

Authors:  Geng-Wen Huang; Lian-Yue Yang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

8.  Distribution of intrahepatic mast cells in various hepatobiliary disorders. An immunohistochemical study.

Authors:  M Yamashiro; W Kouda; N Kono; K Tsuneyama; O Matsui; Y Nakanuma
Journal:  Virchows Arch       Date:  1998-11       Impact factor: 4.064

9.  Mast cell density, hepatic stellate cell activation and TGF-beta1 transcripts in the aging Sprague-Dawley rat during early acute liver injury.

Authors:  F Grizzi; B Franceschini; N Gagliano; C Moscheni; G Annoni; C Vergani; P L Hermonat; M Chiriva-Internati; N Dioguardi
Journal:  Toxicol Pathol       Date:  2003 Mar-Apr       Impact factor: 1.902

10.  Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation.

Authors:  P Bradding; I H Feather; S Wilson; P G Bardin; C H Heusser; S T Holgate; P H Howarth
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

View more
  10 in total

Review 1.  The emerging role of mast cells in liver disease.

Authors:  Veronica Jarido; Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Joanne Thomson; Kristen Stephenson; Heather Francis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-04       Impact factor: 4.052

2.  The in vivo antineoplastic and therapeutic efficacy of troxerutin on rat preneoplastic liver: biochemical, histological and cellular aspects.

Authors:  Nisha Susan Thomas; Kiran George; Sivaranjani Arivalagan; Vijay Mani; Aktarul Islam Siddique; Nalini Namasivayam
Journal:  Eur J Nutr       Date:  2016-08-03       Impact factor: 5.614

3.  Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer.

Authors:  Shi-Yun Tan; Yan Fan; He-Sheng Luo; Zhi-Xiang Shen; Yi Guo; Liang-Jia Zhao
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

4.  Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis.

Authors:  Gopalakrishnan Ramakrishnan; Sundaram Jagan; Sattu Kamaraj; Pandi Anandakumar; Thiruvengadam Devaki
Journal:  Invest New Drugs       Date:  2008-07-30       Impact factor: 3.850

5.  Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings.

Authors:  Kyle Hodges; Lindsey Kennedy; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Transl Gastrointest Cancer       Date:  2012-02-08

Review 6.  The complex functions of mast cells in chronic human liver diseases.

Authors:  Barbara Franceschini; Giorgia Ceva-Grimaldi; Carlo Russo; Nicola Dioguardi; Fabio Grizzi
Journal:  Dig Dis Sci       Date:  2006-11-11       Impact factor: 3.487

7.  Any defining role of mast cell or mast cell density in oral squamous cell carcinoma?

Authors:  O Ozdemir
Journal:  Ann Med Health Sci Res       Date:  2014-11

8.  Mast cells positive to tryptase, endothelial cells positive to protease-activated receptor-2, and microvascular density correlate among themselves in hepatocellular carcinoma patients who have undergone surgery.

Authors:  Michele Ammendola; Rosario Sacco; Giuseppe Sammarco; Tullio Piardi; Valeria Zuccalà; Rosa Patruno; Alessandra Zullo; Nicola Zizzo; Bruno Nardo; Ilaria Marech; Alberto Crovace; Cosmo Damiano Gadaleta; Patrick Pessaux; Girolamo Ranieri
Journal:  Onco Targets Ther       Date:  2016-07-21       Impact factor: 4.147

9.  Hesperetin conjugated PEGylated gold nanoparticles exploring the potential role in anti-inflammation and anti-proliferation during diethylnitrosamine-induced hepatocarcinogenesis in rats.

Authors:  Gokuladhas Krishnan; Jayakumar Subramaniyan; Pramila Chengalvarayan Subramani; Barath Muralidharan; Devaki Thiruvengadam
Journal:  Asian J Pharm Sci       Date:  2017-05-12       Impact factor: 6.598

10.  Mast cells and the liver aging process.

Authors:  Fabio Grizzi; Maurizio Chiriva-Internati; Giuseppe Di Caro; Luigi Laghi; Paul Hermonat; Paolo Mazzola; Diane D Nguyen; Saba Radhi; Jose A Figueroa; Everardo Cobos; Giorgio Annoni
Journal:  Immun Ageing       Date:  2013-03-07       Impact factor: 6.400

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.